Fidelis signs distribution agreement with KAC Co., Ltd., Japan

To start offering biospecimen procurement services on the Japanese market through distribution agreement with KAC Co., Ltd.

Dotted box svg

SOFIA, BULGARIA, 21 Oct 2020

The company now offers its bespoke sample collection solutions to customers in Japan through a non-exclusive distribution agreement with Japanese partner KAC Co., Ltd. The collaboration will see Fidelis expand its customer base and help customers in Japan access high quality tissue and biofluid samples for their research.

) is a privately-owned contract research company focused on the custom procurement and processing of human biological samples from disease state patients. Headquartered in Sofia, Bulgaria, Fidelis also has own operations in Croatia, Moldova, Romania, Serbia and Turkey, thus covering a large network of over 60 collection sites in Europe with the capability to ship samples rapidly to clients around the world.  

) established in 1978, have been offering variety of services to help the pharmaceutical research and development. Having three divisions the Animal Care Division, the Bioscience Division, and the Reagent Business Division, focusing on the Reagent since it started operations in 1994, has provided high quality products - human tissue derived products such as blood, hepatic cells and others.